Brief: Zydus Lifesciences Launches Biosimilar Of Nivolumab In India
Jan 22 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES - LAUNCHES BIOSIMILAR OF NIVOLUMAB IN INDIA ZYDUS LIFESCIENCES - BIOSIMILAR TISHTHA PRICED AT 28,950 RUPEES FOR 100 MG AND 13,950 RUPEES FOR 40 MG Source text: ID:nNSE9BgpH Further company coverage: ZYDU.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka